GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer
Keywords:
Maintenance
Olaparib
Ovarian cancer
Pegylated liposomal doxorubicin
Platinum-resistant
Publisher:
Future Science Ltd
Note:
This work is licensed under the Creative Commons Attribution 4.0 License. To view a copy of this license, visit: http://creativeco
mmons.org/licenses/by/4.0/
Citation:
Perez-Fidalgo, J.A. (J. Alejandro); Iglesias, M. (Maria); Bohn, U. (Uriel); et al. "GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer". Future Science OA. 5 (2), 2019, FSO370
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.